Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single-Dose, Four-Period, Four-Treatment, Four-Way Crossover Relative Bioavailability Study of CL-108 Under Fed and Fasted Conditions

NCT02465866 is registered in ClinicalTrials.gov with Charleston Laboratories, Inc as lead sponsor.

NCT NCT02465866
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02465866 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single-Dose, Four-Period, Four-Treatment, Four-Way Crossover Relative Bioavailability Study of CL-108 Under Fed and Fasted Conditions
Lead sponsor
Charleston Laboratories, Inc
Phase
Phase 1
Overall status
Completed
Start date
November 30, 2014
Completion date
April 30, 2015
Enrollment
20 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

healthy